Prospective comparison of transcatheter arterial chemoembolization with Lipiodol-epirubicin and Lipiodol-cisplatin for treatment of recurrent hepatocellular carcinoma

Japanese Journal of Radiology

Volumn 28, Issue 5, 2010, Pages 362-368

  Sahara, Shinya ^a   Kawai, Nobuyuki ^a   Sato, Morio ^a   Minamiguchi, Hiroki ^a   Nakai, Motoki ^a   Takasaka, Isao ^a   Nakata, Kouhei ^a   Ikoma, Akira ^a   Sawa, Naohisa ^a   Sonomura, Tetsuo ^a   Shirai, Shintaro ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Anticancer drugs; Cisplatin; Epirubicin; Hepatocellular carcinoma; Transcatheter arterial chemoembolization

Indexed keywords

CISPLATIN; EPIRUBICIN; GELATIN SPONGE; IODINATED POPPYSEED OIL; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC;

ABDOMINAL PAIN; ADULT; AGED; ANOREXIA; ARTICLE; CANCER RECURRENCE; CHEMOEMBOLIZATION; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; SIDE EFFECT; THROMBOCYTE; TREATMENT RESPONSE; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; LIVER NEOPLASMS; MIDDLE AGED; PROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR RECURRENCE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; EPIRUBICIN; FEMALE; HUMANS; IODIZED OIL; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77955255583     PISSN: 18671071     EISSN: 1867108X     Source Type: Journal    
DOI: 10.1007/s11604-010-0436-y     Document Type: Article

References (21)

1. J.M. Llovet M.I. Real X. Montana R. Planas S. Coll J. Aponte, et al. 2002 Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomized controlled trial Lancet 359 1734 1739 10.1016/S0140-6736(02)08649-X 12049862 (Pubitemid 34607087)
2. T.J. Liang I.J. Jeffers K.R. Reddy M. Medina I.T. Parkeret H. Cheinquer, et al. 1993 Viral pathogenesis of hepatocellular carcinoma in the United States Hepatology 18 1326 1333 1:STN:280:DyaK2c%2FmtlOltw%3D%3D 8244256
3. G. Fattovich G. Giustina F. Degos F. Tremolada G. Diodati P. Almasio, et al. 1997 Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients Gastroenterology 112 463 472 10.1053/gast.1997.v112.pm9024300 1:STN:280:DyaK2s7ns1Olsw%3D%3D 9024300 (Pubitemid 27078833)
4. R. Yamada M. Sato M. Kawabata K. Nakamura S. Takashima 1983 Hepatic artery embolization in 120 patients with unresectable hepatoma Radiology 148 397 401 1:STN:280:DyaL3s3kvVWhsA%3D%3D 6306721
5. K. Nishimine H. Uchida N. Matsuo H. Sakaguchi S. Hirohashi Y. Nishimura, et al. 1994 Segmental transarterial chemoembolisation with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma; follow-up CT and therapeutic results Cancer Chemother Pharmacol 33 60 68 10.1007/BF00686670
6. S. Kawai M. Tani J. Okamura M. Ogawa Y. Ohashi M. Monden, et al. 1997 Prospective and randomized trial of Lipiodol-transcatheter arterial chemoembolisation for treatment of hepatocellular carcinoma: a comparison of epirubicin and doxorubicin (second cooperative study)-The Cooperative Study Group for Liver Cancer Treatment of Japan Semin Oncol 24 S6 38 45
7. J.P. Bronowicki D. Vetter F. Dumas K. Boudjema R. Bader A.M. Weiss, et al. 1994 Transcatheter oily embolisation for hepatocellular carcinoma: a 4-year study of 127 French patients Cancer 74 16 24 10.1002/1097-0142(19940701)74: 1<16::AID-CNCR2820740105>3.0.CO;2-V 1:STN:280:DyaK2c3ntlSrsw%3D%3D 7516263 (Pubitemid 24187604)
8. Y. Sasaki S. Imaoka H. Kasugai M. Fujita S. Kawamoto S. Ishiguro, et al. 1987 A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge Cancer 60 1194 1203 10.1002/1097- 0142(19870915)60:6<1194::AID-CNCR2820600607>3.0.CO;2-T 1:STN:280:DyaL2szgtFahuw%3D%3D 2441837 (Pubitemid 17152894)
9. K. Takayasu Y. Muramatsu T. Maeda R. Iwata H. Fukuoka N. Moriyama, et al. 2001 Targeted transarterial oily chemoembolisation for small foci of hepatocellular carcinoma using a unified helical CT and angiography system: analysis of factors affecting local recurrence and survival rates AJR Am J Roentgenol 176 681 688 1:STN:280:DC%2BD3M3is1Kkug%3D%3D 11222205
10. H. Kasugai J. Kojima M. Tatsuta S. Okuda Y. Sasaki S. Imaoka, et al. 1989 Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil Gastroenterology 97 965 971 1:STN:280:DyaL1MznvVKktw%3D%3D 2550311
11. T. Konno H. Maeda K. Iwai S. Tashiro S. Maki T. Morinaga, et al. 1983 Effect of arterial administration of high molecular weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report Eur J Cancer Clin Oncol 19 1053 1065 10.1016/0277-5379(83)90028-7 1:STN:280: DyaL2c%2FgsVGgtw%3D%3D 6311559
12. Y. Ono T. Yoshimasu R. Ashikaga M. Inoue H. Shindou K. Fuji, et al. 2000 Long-term results of Lipiodol-transcatheter arterial chemoembolisation with cisplatin or doxorubicin for unresectable hepatocellular carcinoma Am J Clin Oncol 23 564 568 10.1097/00000421-200012000-00006 1:STN:280: DC%2BD3M7gvVKnsA%3D%3D 11202797 (Pubitemid 32429101)
13. M. Sato R. Yamada B. Uchida P. Hedgepeth J. Rosch 1993 Effects of hepatic artery embolization with Lipiodol and gelatin sponge particles on normal swine liver Cardiovasc Intervent Radiol 16 348 354 10.1007/BF02603139 1:STN:280:DyaK2c7nslGrtQ%3D%3D 8131165
14. S. Sahara H. Tanihata M. Sato N. Kawai I. Takasaka H. Minamiguchi, et al. 2009 Effects of hepatic artery chemoembolization using cisplatin-Lipiodol suspension with gelatin sponge particles on swine liver J Vasc Interv Radiol 20 1359 1364 10.1016/j.jvir.2009.06.028 19695901
15. M.E. Cooley L. Davis J. Abrahm 1994 Cisplatin: a clinical review. Part II. Nursing assessment and management of side effects of cisplatin Cancer Nurs 17 283 293 1:STN:280:DyaK2M%2Fkt1aktA%3D%3D 7954376
16. S. Maeda J. Shibata S. Fujiyama M. Tanaka S. Noumaru K. Sato, et al. 2003 Long-term follow-up of hepatic arterial chemoembolization with cisplatin suspended in iodized oil for heaptocellular carcinoma Hepatogastroenterology 50 809 813 1:CAS:528:DC%2BD3sXkslGisbo%3D 12828090
17. N. Uyama N. Hatano Y. Maetani H. Isoda T. Shibata K. Taura, et al. 2008 Efficacy and toxicity of transcatheter arterial chemoembolisation with cisplatin suspended in Lipiodol for unresectable hepatocellular carcinoma Jpn J Cancer Chemother 35 775 780
18. M. Masuda 2002 Evaluation of basic and clinical study on effect of anticancer drugs of Lipiodol in chemoembolization on liver tissue J Wakayama Med Soc 53 185 192 1:CAS:528:DC%2BD38Xot1CntLk%3D
19. K. Kamada T. Nakanishi M. Kitamoto H. Aikata Y. Kawakami S. Imaoka, et al. 2001 Long-term prognosis of patients undergoing transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: comparison of cisplatin Lipiodol suspension and doxorubicin hydrochloride emulsion J Vasc Interv Radiol 12 847 854 10.1016/S1051-0443(07)61510-3 1:STN:280: DC%2BD3MznvFaqtQ%3D%3D 11435541
20. J.M. Chang W.S. Tzeng H.B. Pan C.F. Yang K.H. Lai, et al. 1994 Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma: a randomized controlled study Cancer 74 2449 2453 10.1002/1097-0142(19941101)74:9<2449::AID-CNCR2820740910>3.0.CO;2-4 1:STN:280:DyaK2M%2FgslersA%3D%3D 7922999 (Pubitemid 24320847)
21. Liver Cancer Study Group of Japan. The general rules for the clinical and pathological study of primary liver cancer. 5th edition, revised version. Tokyo: Kanehara; 2009 p. 29-34.